A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Drugs in Dermatology
DOI: 10.36849/jdd.9222
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7118488874
